波罗样类激酶1激活调节了来自小鼠的尾和小介质动脉中的 ангиотензинII诱导的收缩
Raiana Anjos Moraes1,2, Olufunke O Arishe3, James Pratt1
1Cardiovascular Translational Research Center, University of South Carolina, Columbia, SC 29209, USA.
Cells
|November 13, 2025
概括
波罗样类激酶1 (PLK1) 调节平滑肌肉收缩. 抑制PLK1减少了Ang II诱导的血管收缩和神经性勃起反应,这表明刺激的特定作用.
科学领域:
- 生理学 生理学 生理学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 波罗样类激酶1 (PLK1) 是一种在光滑肌细胞 (SMC) 中发现的氨酸/氨酸激酶.
- 新出现的证据表明PLK1在调节SMC收缩方面发挥作用.
- 它对血管和勃起组织的特殊贡献需要进一步研究.
研究的目的:
- 为了研究PLK1在光滑肌肉收缩性中的作用.
- 为了确定PLK1是否调节尾动脉 (PA),小介质动脉 (SMA) 和洞腔体 (CC) 的收缩.
- 评估PLK1抑制对SMC对各种收缩刺激反应的影响.
主要方法:
- 评估了来自雄性C57BL/6J小鼠的PA,SMA和CC中的PLK1mRNA和蛋白质表达.
- 在孤立的动脉和CC中利用肌肉图谱进行同度力测量.
- 给PLK1抑制剂Volasertib进行治疗,以评估其对刺激引起的收缩的影响.
主要成果:
- 在PA,SMA和CC中证实了PLK1的表达.
- 抑制PLK1显著降低了在PA和SMA中Ang II诱导的收缩.
- PLK1抑制减弱电场刺激 (EFS) 诱导的2和4赫兹的CC收缩.
- 对 fenilephrine (PE),U46619和血清素 (5-HT) 的反应不受PLK1抑制的影响.
结论:
- PLK1选择性地调节平滑肌肉收缩,以应对Ang II和神经刺激.
- PLK1在血管和勃起组织中起到刺激特异性调节者的作用.
- 对于涉及异常光滑肌肉收缩性的疾病,PLK1代表了一个潜在的新型治疗标.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K


